わかもと製薬株式会社 · WAKAMOTO PHARMACEUTICAL CO.,LTD.
Last · Tokyo¥298.00-3.00 (-1.00%)close · yahoo · 9h ago
Vol 49.8K ≈ 14.84M
MA10MA20MA50
Market cap¥10.3B34.7M sh
P/E · TTM30.2fwd — · eps 9.88
Beta0.45vs S&P 500
Div yield1.17%annual · TTM
52w range
¥240.00¥380.00
Volume49.8Ksession
Issuer
Legal nameWAKAMOTO PHARMACEUTICAL CO.,LTD. · わかもと製薬株式会社
HQJapan (JP)
ListingJP 4512
ISINJP3991200001
SectorHealthcare
IndustryPharmaceuticals
CurrencyJPY
Entity registryedinet:E00928
Org IDE00928
Websitewww.wakamoto-pharm.co.jp
Employees403
AddressWakamoto Pharmaceutical Co., Ltd. 2-2-2 Nihonbashi Hon-cho 103-8330, Tokyo
| Revenue | ¥9.9B |
|---|---|
| Operating income | ¥255.5M |
| Net income | ¥227.2M |
| Free cash flow | ¥-924.9M |
| Operating margin | 2.6% |
| Net margin | 2.3% |
| Return on equity | 2.1% |
| Period | 2026 |
Loading chart…
OpenFilings analyst
Our analyst
ANNUAL · 2026-06-18
From latest ANNUAL · 2026-06-18
- Operating Cf Burn
Red flags
- Operating Cf Burn — Negative operating cash flow
Documents
FormReporting forFiledFlags
Showing 5 of 40 filings